IDEAS home Printed from https://ideas.repec.org/a/aio/manmar/vxiiiy2015i1p188-204.html

Global Public Private Partnership: An Analogical Reasoning Model

Author

Listed:
  • Hyuk KIM

    (Otterbein University, Westerville, USA)

Abstract

This paper aims to introduce a new strategic direction for the multinational pharmaceutical companies in terms of the access to essential, life-saving medicines. The multinational pharmaceutical companies have been severely criticized by their various stakeholders because of their business models, particularly because of the stringent patent protection on the pharmaceutical products. The multinational pharmaceutical companies should find a new strategic direction to balance their R&D-intensive, expensive business with the access to essential, lifesaving medicines since favorable public relations are critical for the multinational pharmaceutical companies to maintain their profitable business. This paper adopts an Analogical Reasoning Model (ARM) to propose a new strategic direction for the multinational pharmaceutical companies in an effort to balance their expensive business with the enhanced social responsibility. In essence, the ARM helps the multinational pharmaceutical companies formulate viable strategies that can realize a win-win situation not only for their stakeholders but also for the pharmaceutical companies themselves. The ARM is constructed, analyzing the food and beverage industry as a source environment, and suggests a comprehensive, industry-wide, multi-stakeholder public-private partnership, led not by the public sector but by the multinational pharmaceutical companies.

Suggested Citation

  • Hyuk KIM, 2015. "Global Public Private Partnership: An Analogical Reasoning Model," Management and Marketing Journal, University of Craiova, Faculty of Economics and Business Administration, vol. 0(1), pages 188-204, May.
    • Handle: RePEc:aio:manmar:v:xiii:y:2015:i:1:p:188-204
    as

    Download full text from publisher

    File URL: http://www.mnmk.ro/documents/2015_X1/15-15-1-15.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Patricia Danzon, 1997. "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 301-322.
    2. Farid Gasmi & Paul Noumba Um & Laura Recuero Virto, 2009. "Political Accountability and Regulatory Performance in Infrastructure Industries: An Empirical Analysis," The World Bank Economic Review, World Bank, vol. 23(3), pages 509-531, October.
    3. World Bank, 2006. "Repositioning Nutrition as Central to Development : A Strategy for Large Scale Action," World Bank Publications - Books, The World Bank Group, number 7409, April.
    4. Stern, Jon & Cubbin, John, 2005. "Regulatory effectiveness : the impact of regulation and regulatory governance arrangements on electricity industry outcomes," Policy Research Working Paper Series 3536, The World Bank.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Recuero Virto, Laura & Gasmi, Farid & Noumba Um, Paul, 2009. "The role of institutional design in the conduct of infrastructure industries reforms - An illustration through telecommunications in developing countries," MPRA Paper 12881, University Library of Munich, Germany.
    2. Bertoméu-Sánchez, Salvador & Camos, Daniel & Estache, Antonio, 2018. "Do economic regulatory agencies matter to private-sector involvement in water utilities in developing countries?," Utilities Policy, Elsevier, vol. 50(C), pages 153-163.
    3. Antonio Estache & Liam Wren-Lewis, 2008. "Towards a Theory of Regulation for Developing Countries: Following Laffont's Lead," Working Papers ECARES 2008_018, ULB -- Universite Libre de Bruxelles.
    4. Recuero Virto, Laura & Gasmi, Farid & Belaid, Rabah, 2009. "Qualité institutionnelle et performance économique : cas des télécommunications dans les pays en voie de développement [Institutional quality and economic performance through telecommunications in developing countries]," MPRA Paper 12889, University Library of Munich, Germany.
    5. Recuero Virto, Laura & Gasmi, Farid & Noumba Um, Paul, 2008. "The Role of Institutional Design in the Conduct of Infrastructure Industry Reforms - An Illustration through Telecommunications in Developing Countries," MPRA Paper 28253, University Library of Munich, Germany, revised 2008.
    6. Azmat Gani, 2015. "Air Quality and Under-five Mortality Rates in the Low-income Countries," Journal of Development Studies, Taylor & Francis Journals, vol. 51(7), pages 851-864, July.
    7. Emily Levitt & Kees Kostermans & Luc Laviolette & Nkosinathi Mbuya, 2011. "Malnutrition in Afghanistan : Scale, Scope, Causes, and Potential Response," World Bank Publications - Books, The World Bank Group, number 2518, April.
    8. Guaracyane Lima Campelo & João Mário Santos De França & Emerson Luís Lemos Marinho, 2016. "Impacts Of Malnutrition On Labor Productivity: Empirical Evidences In Rural Brazil," Anais do XLII Encontro Nacional de Economia [Proceedings of the 42nd Brazilian Economics Meeting] 236, ANPEC - Associação Nacional dos Centros de Pós-Graduação em Economia [Brazilian Association of Graduate Programs in Economics].
    9. Adelman, Sarah W. & Gilligan, Daniel O. & Lehrer, Kim, 2008. "How effective are food for education programs? : A critical assessment of the evidence from developing countries," Food Policy Reviews 48852, CGIAR, International Food Policy Research Institute (IFPRI).
    10. Shi, Wunan & Wouters, Olivier J. & Liu, Gordon & Mossialos, Elias & Yang, Xiuyun, 2020. "Association between provincial income levels and drug prices in China over the period 2010–2017," Social Science & Medicine, Elsevier, vol. 263(C).
    11. Begoña Garcia Mariñoso & Izabela Jelovac & Pau Olivella, 2011. "External referencing and pharmaceutical price negotiation," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 737-756, June.
    12. Gregory J. King & Xiuli Chao & Izak Duenyas, 2019. "Who Benefits When Prescription Drug Manufacturers Offer Copay Coupons?," Management Science, INFORMS, vol. 65(8), pages 3758-3775, August.
    13. Joseph E. Stiglitz, 2012. "Macroeconomic Fluctuations, Inequality, and Human Development," Journal of Human Development and Capabilities, Taylor & Francis Journals, vol. 13(1), pages 31-58, February.
    14. Graeme Guthrie, 2006. "Regulating Infrastructure: The Impact on Risk and Investment," Journal of Economic Literature, American Economic Association, vol. 44(4), pages 925-972, December.
    15. Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari, 2008. "Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy," NBER Working Papers 14567, National Bureau of Economic Research, Inc.
    16. Li, Yan, 2011. "The competitive landscape of China’s telecommunications industry: Is there a need for further regulatory reform?," Utilities Policy, Elsevier, vol. 19(3), pages 125-133.
    17. Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.
    18. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
    19. Jane Dixon, 2009. "From the imperial to the empty calorie: how nutrition relations underpin food regime transitions," Agriculture and Human Values, Springer;The Agriculture, Food, & Human Values Society (AFHVS), vol. 26(4), pages 321-333, December.
    20. Chatterjee, Chirantan & Kubo, Kensuke & Pingali, Viswanath, 2015. "The consumer welfare implications of governmental policies and firm strategy in markets for medicines," Journal of Health Economics, Elsevier, vol. 44(C), pages 255-273.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    JEL classification:

    • M30 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Marketing and Advertising - - - General
    • M31 - Business Administration and Business Economics; Marketing; Accounting; Personnel Economics - - Marketing and Advertising - - - Marketing

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aio:manmar:v:xiii:y:2015:i:1:p:188-204. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catalin Barbu (email available below). General contact details of provider: https://edirc.repec.org/data/fecraro.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.